Top Back to top

Non-interventional prospective study on the on the effect of 2nd generation TKI prior to HSCT in CML

Chronic Malignancies Working Party (CMWP)
Study number:
42201038
Type of transplant:
 
Short title:
 
Study status:
Ongoing
Deadline for data collection:
 
Study design:
 
Primary objective:
 
Key inclusion criteria:
>18years old; allogeneic HSCT; CML; Dasatinib or Nilotinib
Country:
 
Principal investigator:
Michael Schleuning
Principal investigator email:
 
EBMT Study coordinator:
Jennifer Hoek